These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 11741881)

  • 1. Dystroglycan is not required for localization of dystrophin, syntrophin, and neuronal nitric-oxide synthase at the sarcolemma but regulates integrin alpha 7B expression and caveolin-3 distribution.
    Côté PD; Moukhles H; Carbonetto S
    J Biol Chem; 2002 Feb; 277(7):4672-9. PubMed ID: 11741881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interactions between dystrophin and the sarcolemma membrane.
    Chamberlain JS; Corrado K; Rafael JA; Cox GA; Hauser M; Lumeng C
    Soc Gen Physiol Ser; 1997; 52():19-29. PubMed ID: 9210217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of caveolin-3 in skeletal, cardiac, and smooth muscle cells. Caveolin-3 is a component of the sarcolemma and co-fractionates with dystrophin and dystrophin-associated glycoproteins.
    Song KS; Scherer PE; Tang Z; Okamoto T; Li S; Chafel M; Chu C; Kohtz DS; Lisanti MP
    J Biol Chem; 1996 Jun; 271(25):15160-5. PubMed ID: 8663016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of the skeletal muscle dystrophin-dystroglycan complex and syntrophin-nitric oxide synthase complex is severely affected in the type 2 diabetic Goto-Kakizaki rat.
    Mulvey C; Harno E; Keenan A; Ohlendieck K
    Eur J Cell Biol; 2005 Nov; 84(11):867-83. PubMed ID: 16323284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dystroglycan contributes to the formation of multiple dystrophin-like complexes in brain.
    Moukhles H; Carbonetto S
    J Neurochem; 2001 Aug; 78(4):824-34. PubMed ID: 11520903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Constitutive properties, not molecular adaptations, mediate extraocular muscle sparing in dystrophic mdx mice.
    Porter JD; Merriam AP; Khanna S; Andrade FH; Richmonds CR; Leahy P; Cheng G; Karathanasis P; Zhou X; Kusner LL; Adams ME; Willem M; Mayer U; Kaminski HJ
    FASEB J; 2003 May; 17(8):893-5. PubMed ID: 12670877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Localization of sarcoglycan, neuronal nitric oxide synthase, beta-dystroglycan, and dystrophin molecules in normal skeletal myofiber: triple immunogold labeling electron microscopy.
    Wakayama Y; Inoue M; Kojima H; Murahashi M; Shibuya S; Oniki H
    Microsc Res Tech; 2001 Nov; 55(3):154-63. PubMed ID: 11747090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic compensation for sarcoglycan loss by integrin alpha7beta1 in muscle.
    Allikian MJ; Hack AA; Mewborn S; Mayer U; McNally EM
    J Cell Sci; 2004 Aug; 117(Pt 17):3821-30. PubMed ID: 15252120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transgenic overexpression of caveolin-3 in skeletal muscle fibers induces a Duchenne-like muscular dystrophy phenotype.
    Galbiati F; Volonte D; Chu JB; Li M; Fine SW; Fu M; Bermudez J; Pedemonte M; Weidenheim KM; Pestell RG; Minetti C; Lisanti MP
    Proc Natl Acad Sci U S A; 2000 Aug; 97(17):9689-94. PubMed ID: 10931944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of sarcolemma nNOS in sarcoglycan-deficient muscle.
    Crosbie RH; Barresi R; Campbell KP
    FASEB J; 2002 Nov; 16(13):1786-91. PubMed ID: 12409321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dystroglycan and muscular dystrophies related to the dystrophin-glycoprotein complex.
    Sciandra F; Bozzi M; Bianchi M; Pavoni E; Giardina B; Brancaccio A
    Ann Ist Super Sanita; 2003; 39(2):173-81. PubMed ID: 14587215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The dystrophin glycoprotein complex: signaling strength and integrity for the sarcolemma.
    Lapidos KA; Kakkar R; McNally EM
    Circ Res; 2004 Apr; 94(8):1023-31. PubMed ID: 15117830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential targeting of nNOS and AQP4 to dystrophin-deficient sarcolemma by membrane-directed alpha-dystrobrevin.
    Adams ME; Tesch Y; Percival JM; Albrecht DE; Conhaim JI; Anderson K; Froehner SC
    J Cell Sci; 2008 Jan; 121(Pt 1):48-54. PubMed ID: 18057022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Caveolin-3 is not an integral component of the dystrophin glycoprotein complex.
    Crosbie RH; Yamada H; Venzke DP; Lisanti MP; Campbell KP
    FEBS Lett; 1998 May; 427(2):279-82. PubMed ID: 9607328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo requirement of the alpha-syntrophin PDZ domain for the sarcolemmal localization of nNOS and aquaporin-4.
    Adams ME; Mueller HA; Froehner SC
    J Cell Biol; 2001 Oct; 155(1):113-22. PubMed ID: 11571312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dissociation of the dystroglycan complex in caveolin-3-deficient limb girdle muscular dystrophy.
    Herrmann R; Straub V; Blank M; Kutzick C; Franke N; Jacob EN; Lenard HG; Kröger S; Voit T
    Hum Mol Genet; 2000 Sep; 9(15):2335-40. PubMed ID: 11001938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ultrastructural localization of alpha 1-syntrophin and neuronal nitric oxide synthase in normal skeletal myofiber, and their relation to each other and to dystrophin.
    Wakayama Y; Inoue M; Murahashi M; Shibuya S; Jimi T; Kojima H; Oniki H
    Acta Neuropathol; 1997 Nov; 94(5):455-64. PubMed ID: 9386778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Co-localization of nitric oxide synthase I (NOS I) and NMDA receptor subunit 1 (NMDAR-1) at the neuromuscular junction in rat and mouse skeletal muscle.
    Grozdanovic Z; Gossrau R
    Cell Tissue Res; 1998 Jan; 291(1):57-63. PubMed ID: 9394043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extraocular muscle is spared despite the absence of an intact sarcoglycan complex in gamma- or delta-sarcoglycan-deficient mice.
    Porter JD; Merriam AP; Hack AA; Andrade FH; McNally EM
    Neuromuscul Disord; 2001 Mar; 11(2):197-207. PubMed ID: 11257478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relocalization of neuronal nitric oxide synthase (nNOS) as a marker for complete restoration of the dystrophin associated protein complex in skeletal muscle.
    Wells KE; Torelli S; Lu Q; Brown SC; Partridge T; Muntoni F; Wells DJ
    Neuromuscul Disord; 2003 Jan; 13(1):21-31. PubMed ID: 12467729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.